Search
Close this search box.
Search
Close this search box.

Dr Harriet Gray Stephens discusses the pros and cons of synthetic control arms in clinical trials

An article authored by Dr Harriet Gray Stephens MFPM, medical director at Boyds, has been published on the Clinical Leader website.

Synthetic control arms are an innovative approach that is increasingly being adopted in clinical trials and a type of external control arm study.

Harriet’s article: ‘The pros and cons of synthetic control arms in clinical trials’ discusses the ideal data sources for synthetic control arms (SCAs), regulators’ views on SCAs, and the advantages and limitations of the approach.

Click here to read the full article on Clinical Leader.

For further advice or support, get in touch with the Boyds clinical and medical affairs team.

Facebook
Twitter
LinkedIn